NL128191C - - Google Patents

Info

Publication number
NL128191C
NL128191C NL128191DA NL128191C NL 128191 C NL128191 C NL 128191C NL 128191D A NL128191D A NL 128191DA NL 128191 C NL128191 C NL 128191C
Authority
NL
Netherlands
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of NL128191C publication Critical patent/NL128191C/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
NL128191D 1965-01-12 NL128191C (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH41465A CH458365A (de) 1965-01-12 1965-01-12 Verfahren zur Herstellung von neuen Picolylamin-Derivaten

Publications (1)

Publication Number Publication Date
NL128191C true NL128191C (cg-RX-API-DMAC7.html)

Family

ID=4186481

Family Applications (2)

Application Number Title Priority Date Filing Date
NL128191D NL128191C (cg-RX-API-DMAC7.html) 1965-01-12
NL6600250A NL6600250A (cg-RX-API-DMAC7.html) 1965-01-12 1966-01-10

Family Applications After (1)

Application Number Title Priority Date Filing Date
NL6600250A NL6600250A (cg-RX-API-DMAC7.html) 1965-01-12 1966-01-10

Country Status (11)

Country Link
US (1) US3350400A (cg-RX-API-DMAC7.html)
BE (1) BE674919A (cg-RX-API-DMAC7.html)
BR (1) BR6676358D0 (cg-RX-API-DMAC7.html)
CH (1) CH458365A (cg-RX-API-DMAC7.html)
DE (1) DE1545772B1 (cg-RX-API-DMAC7.html)
DK (1) DK114482B (cg-RX-API-DMAC7.html)
ES (1) ES321531A1 (cg-RX-API-DMAC7.html)
FR (2) FR1463438A (cg-RX-API-DMAC7.html)
GB (1) GB1084150A (cg-RX-API-DMAC7.html)
IT (1) IT7830644A0 (cg-RX-API-DMAC7.html)
NL (2) NL6600250A (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4406903A (en) * 1981-01-21 1983-09-27 John Wyeth And Brother Limited Xanthine derivatives useful as antidepressives
OA12905A (en) 2002-08-19 2006-10-13 Pfizer Prod Inc Combination therapy for hyperproliferative diseases.
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
CN101663262B (zh) 2006-12-01 2014-03-26 百时美施贵宝公司 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
MX2015014666A (es) 2013-04-17 2016-03-01 Pfizer Derivados de n-piperidin-3-ilbenzamida para tratar enfermedades cardiovasculares.
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
US11248001B2 (en) 2019-01-18 2022-02-15 Astrazeneca Ab PCSK9 inhibitors and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3032554A (en) * 1962-05-01 Process for the preparation of new
DE1011424B (de) * 1954-04-17 1957-07-04 Chemiewerk Homburg Ag Verfahren zur Herstellung von basisch substituierten 7-Alkyl-xanthinderivaten oder deren Salzen
US3029239A (en) * 1954-04-17 1962-04-10 Chemiewerk Homburg Zweignieder Basic substituted 1-and 7-alkylxanthines or salts thereof
DE1018869B (de) * 1954-12-14 1957-11-07 Boehringer Sohn Ingelheim Verfahren zur Herstellung von Aminoalkylpurinderivaten
DE1112983B (de) * 1958-11-21 1961-08-24 Sandoz Ag Verfahren zur Herstellung von Theophyllin-Derivaten
CH402872A (de) * 1959-12-18 1965-11-30 Nippon Shinyaku Co Ltd Verfahren zur Herstellung von Theophyllin- oder Theobromin-Derivaten

Also Published As

Publication number Publication date
ES321531A1 (es) 1966-11-01
GB1084150A (cg-RX-API-DMAC7.html)
FR5128M (cg-RX-API-DMAC7.html) 1967-06-05
BR6676358D0 (pt) 1973-09-06
NL6600250A (cg-RX-API-DMAC7.html) 1966-07-13
US3350400A (en) 1967-10-31
DK114482B (da) 1969-07-07
FR1463438A (fr) 1966-12-23
CH458365A (de) 1968-08-30
IT7830644A0 (it) 1978-12-06
DE1545772B1 (de) 1969-12-11
BE674919A (cg-RX-API-DMAC7.html) 1966-07-11

Similar Documents

Publication Publication Date Title
BE674763A (cg-RX-API-DMAC7.html)
FR5128M (cg-RX-API-DMAC7.html)
AU416230B2 (cg-RX-API-DMAC7.html)
BE675187A (cg-RX-API-DMAC7.html)
BE674905A (cg-RX-API-DMAC7.html)
BE589507A (cg-RX-API-DMAC7.html)
BE660633A (cg-RX-API-DMAC7.html)
BE660960A (cg-RX-API-DMAC7.html)
BE661015A (cg-RX-API-DMAC7.html)
BE661729A (cg-RX-API-DMAC7.html)
BE663084A (cg-RX-API-DMAC7.html)
BE665432A (cg-RX-API-DMAC7.html)
BE665788A (cg-RX-API-DMAC7.html)
BE666447A (cg-RX-API-DMAC7.html)
BE668441A (cg-RX-API-DMAC7.html)
BE668544A (cg-RX-API-DMAC7.html)
BE669732A (cg-RX-API-DMAC7.html)
BE671542A (cg-RX-API-DMAC7.html)
BE672147A (cg-RX-API-DMAC7.html)
BE672486A (cg-RX-API-DMAC7.html)
BE672573A (cg-RX-API-DMAC7.html)
BE673491A (cg-RX-API-DMAC7.html)
BE673904A (cg-RX-API-DMAC7.html)
BE674278A (cg-RX-API-DMAC7.html)
BE674328A (cg-RX-API-DMAC7.html)